Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Bridgebio Pharma, Inc. (BBIO)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bridgebio Pharma, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Bridgebio Pharma, Inc. since 2005.
The reporting company's ticker symbol is BBIO. The reporting company's CIK number is 1743881.
The total value of stock buying since 2005 is $286,302,100.
The total value of stock sales since 2005 is $9,140,220.
The total value of stock option exercises since 2005 is $340,000.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-14||Homcy Charles J (Chairman of Pharmaceuticals)||Sale||10,000||35.00||350,000|
|2020-01-14||Homcy Charles J (Chairman of Pharmaceuticals)||Option Ex||10,000||17.00||170,000|
|2020-01-08||Turtle Cameron (See Remarks)||Sale||12,807||34.44||441,073|
|2020-01-08||Turtle Cameron (See Remarks)||Option Ex||10,000||17.00||170,000|
|2020-01-03||Stephenson Brian C (See Remarks)||Sale||3,636||32.12||116,806|
|2020-01-03||Henderson Michael Thomas (See Remarks)||Sale||358||32.64||11,685|
|2020-01-03||Kumar Neil (See Remarks)||Sale||83,939||32.51||2,729,024|
|2020-01-02||Stephenson Brian C (See Remarks)||Sale||7,164||33.86||242,573|
|2020-01-02||Henderson Michael Thomas (See Remarks)||Sale||3,617||33.58||121,469|
|2020-01-02||Kumar Neil (See Remarks)||Sale||36,061||33.83||1,219,943|
|2019-12-30||Mccormick Frank (Chairman of Oncology)||Sale||17,150||36.30||622,562|
|2019-12-27||Mccormick Frank (Chairman of Oncology)||Sale||82,850||39.65||3,285,085|
|2019-07-01||Kkr Genetic Disorder Gp Llc (10% Owner)||Buy||2,647,100||17.00||45,000,700|
|2019-07-01||Stephenson Brian C (See Remark)||Buy||55,500||17.00||943,500|
|2019-07-01||Stephenson Brian C (See Remark)||Option Ex||312,946||.00||0|
|2019-07-01||Henderson Michael Thomas (See Remarks)||Buy||7,000||17.00||119,000|
|2019-07-01||Henderson Michael Thomas (See Remarks)||Option Ex||173,767||.00||0|
|2019-07-01||Turtle Cameron (See Remarks)||Option Ex||12,630||.00||0|
|2019-07-01||Sinha Uma (Chief Scientific Officer)||Buy||14,000||17.00||238,000|
|2019-07-01||Kumar Neil (See Remarks)||Option Ex||8,952,428||.00||0|
|2019-07-01||Mccormick Frank (Chairman of Oncology)||Option Ex||1,361,426||.00||0|
|2019-07-01||Scheller Richard H (See Remarks)||Option Ex||163,427||.00||0|
|2019-07-01||Homcy Charles J (Chairman of Pharmaceuticals)||Option Ex||1,361,426||.00||0|
|2019-06-27||Shabet Rose Sharon||Buy||9,411,800||17.00||160,000,600|
Insider trading activities including stock purchases, stock sales, and option exercises of BBIO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bridgebio Pharma, Inc. (symbol BBIO, CIK number 1743881) see the Securities and Exchange Commission (SEC) website.